drugset / Trial / NCT00309777

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

NCT00309777

Phase 3 Completed 857 enrolled Kowa Research Europe
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin.

Timeline

Start
2005-09
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 2 mg
Subject Pitavastatin Small molecule 4 mg
Comparator Simvastatin Small molecule 20 mg
Comparator Simvastatin Small molecule 40 mg

Indications